FIP President Paul Sinclair AM MPS (left)[/caption]
‘Health care across the world is changing very quickly. It’s being driven by innovation, and pharmacists historically have embraced innovation and technology,' he said.
‘What excites me most about our profession at the moment is that we have the chance to do more. Our scope of practice is expanding rapidly, and with that comes opportunities to help more people deliver more outcomes and improve the health system.'
[post_title] => What are pharmacists doing in other countries?
[post_excerpt] => Pharmacists present to the International Pharmaceutical Federation (FIP) on unique services in their country to improve health and safety.
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => what-are-pharmacists-doing-in-other-countries
[to_ping] =>
[pinged] =>
[post_modified] => 2024-09-04 16:43:37
[post_modified_gmt] => 2024-09-04 06:43:37
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://www.australianpharmacist.com.au/?p=27474
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[title_attribute] => What are pharmacists doing in other countries?
[title] => What are pharmacists doing in other countries?
[href] => https://www.australianpharmacist.com.au/what-are-pharmacists-doing-in-other-countries/
[module_atts:td_module:private] => Array
(
)
[td_review:protected] => Array
(
)
[is_review:protected] =>
[post_thumb_id:protected] => 27493
[authorType] =>
)
Debbie Rigby FPS explaining how to correctly use different inhaler devices[/caption]
FIP award winner Dr Sarah Dineen-Griffin fourth from left[/caption]
Shania Liu received the Early Career in Pharmaceutical Practice Recognition Award. Presented every 3 years, the award recognises an educational program or innovation that promotes excellence in learning and teaching in any pharmacy discipline.
Dr Liu is the immediate past Chair of the Pain Management Leadership Committee of the Society of Hospital Pharmacists of Australia. Her research involved the improvement of the safe use of opioids before and after surgery.
Currently, she is a Postdoctoral Research Fellow in the Faculty of Medicine and Dentistry at the University of Alberta, Canada.
Sarah Dineen-Griffin was one of 10 new Fellows of FIP appointed at the Congress. FIP Fellowship recognises individual FIP members who have exhibited strong leadership internationally, distinguished themselves in pharmacy practice or the pharmaceutical sciences and who have contributed to the advancement of the practice of pharmacy or pharmaceutical sciences.
Dr Dineen-Griffin is a full-time teaching and research academic in the School of Biomedical Sciences and Pharmacy at the University of Newcastle. Currently she is Chief Investigator and Project Lead for the NSW/ACT Government Scope of Practice Pharmacy Trials. She is also the Vice President of the FIP Community Pharmacy Section.
[post_title] => FIP congress and two Australians honoured
[post_excerpt] => Find out what pharmacy topics are being discussed on the world stage at FIP, along with the Australians who received top honours.
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => fip-congress-and-two-australians-honoured
[to_ping] =>
[pinged] =>
[post_modified] => 2024-09-03 11:02:11
[post_modified_gmt] => 2024-09-03 01:02:11
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://www.australianpharmacist.com.au/?p=27411
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[title_attribute] => FIP congress and two Australians honoured
[title] => FIP congress and two Australians honoured
[href] => https://www.australianpharmacist.com.au/fip-congress-and-two-australians-honoured/
[module_atts:td_module:private] => Array
(
)
[td_review:protected] => Array
(
)
[is_review:protected] =>
[post_thumb_id:protected] => 27414
[authorType] =>
)
Queensland-based GP pharmacist Amy Gibson MPS[/caption]
Case scenarios
Gavin, 45, is admitted to your hospital for elective surgery on his anterior cruciate ligament (ACL) after rupturing it playing soccer. He is otherwise fit and well, apart from mild hypertension, for which he takes irbesartan with hydrochlorothiazide 150/25 mg daily. Routine blood tests taken at the time of surgery (12 hours ago now) reveal a serum potassium of 3.1 mmol/L (mild hypokalaemia).
Grace, 75, is admitted to hospital with rapid atrial fibrillation (heart rate is 130 bpm), signs of confusion and an infective exacerbation of COPD. She has a history of stage 1 (mild) chronic kidney disease, pulmonary hypertension and subsequent right-sided heart failure secondary to COPD. She takes furosemide 40 mg twice daily, irbesartan 150 mg daily and an indacaterol 110 mcg plus glycopyrronium 50 mcg inhaler, 1 dose daily. A blood test on admission reveals a serum potassium of 3.3 mmol/L (mild hypokalaemia).
Learning ObjectivesAfter reading this article, pharmacists should be able to:
Competency standards (2016) addressed: 1.1, 1.3, 1.4, 1.5, 3.1, 3.2, 3.3, 3.5 Accreditation number: CAP2407AMKW Accreditation expiry: 30/06/2027 |
THIS IS A CPD ARTICLE. YOU NEED TO BE A PSA MEMBER AND LOGGED IN TO READ MORE.
